Ocugen Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Ocugen has a total shareholder equity of $16.9M and total debt of $2.9M, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are $40.5M and $23.6M respectively.

Wichtige Informationen

16.9%

Verhältnis von Schulden zu Eigenkapital

US$2.86m

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$15.70m
EigenkapitalUS$16.93m
GesamtverbindlichkeitenUS$23.62m
GesamtvermögenUS$40.54m

Jüngste Berichte zur Finanzlage

Recent updates

Ocugen announces peer-reviewed publication on COVID-19 vaccine

Sep 14

Ocugen initiated with Buy at Mizuho citing favorable setup ahead of key readout

Aug 23

Ocugen Q2 2022 Earnings Preview

Aug 04

Ocugen: A First Take

Jul 18

Ocugen in renewed focus as FDA wants COVID boosters to fight Omicron variant

Jul 05

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: OCGN's short term assets ($18.6M) exceed its short term liabilities ($18.0M).

Langfristige Verbindlichkeiten: OCGN's short term assets ($18.6M) exceed its long term liabilities ($5.6M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: OCGN has more cash than its total debt.

Schulden abbauen: OCGN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Bilanz


Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: OCGN has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Vorhersage Cash Runway: OCGN is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Entdecken Sie finanziell stabile Unternehmen